Trade HQL anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
abrdn Life Sciences Investors (HQL) is trading at US$20.98, down 2.67% today as of Aug 28, 12:43 EDT. The company has a market capitalisation of US$680.53M. Over the past 52 weeks, HQL has traded between US$13.82 and US$22.67. On Syfe you can trade HQL with $0 commission and add it to your watchlist.
| Previous close | US$21.55 |
|---|---|
| Market cap | US$680.53M |
| 52-week range | US$13.82 – US$22.67 |
| Dividend yield | 10.39% |
| Volume | 107.73K |
| Exchange | US |
Add to Watchlist
Set Price Alert
abrdn Life Sciences Investors
abrdn Healthcare Investors operates as a closed-end investment fund, which engages in the investment in the life sciences industry. It invests in biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals and healthcare information technology and services. The company was founded on February 20, 1992 and is headquartered in Boston, MA.
Year: 1992
abrdn Life Sciences Investors (HQL) stock is trading at US$20.98, -2.67% from the previous close of US$21.55.
The market cap for abrdn Life Sciences Investors (HQL) stock is approximately US$680.53M.
The 52-week high for abrdn Life Sciences Investors (HQL) stock is US$22.67.
The 52-week low for abrdn Life Sciences Investors (HQL) stock is US$13.82.
Yes, abrdn Life Sciences Investors (HQL) pays a dividend. The trailing 12-month dividend yield is 10.39%.
Stay on top of HQL
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
